69.8%, p < 0.001) and competing risk-adjusted cumulative incidence for HRAE was higher, but did not reach statistical significance ( p = 0.11), one-year HRAE-free survival was also reduced (68.5% vs. 85.7%, p = 0.03).
← all excerpts
Prognostic Significance of Albumin in Modern Left Ventricular Assist Device Therapy: Relevance in the HeartMate 3 Era?
1
0.1100
0.1100